Cyclophosphamide 3 g/m2 and G-CSF is an effective and safe outpatient-based PBSC mobilising regimen: A single centre experience [1]

Bone Marrow Transplantation

Volumn 20, Issue 1, 1997, Pages 91-93

  Jindra, P ^a   Koza, V ^a   Cetkovsky, P ^a   Vozobulova, V ^a   Schutzova, M ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AUTOTRANSPLANTATION; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; HODGKIN DISEASE; HUMAN; HUMAN CELL; LETTER; LEUKAPHERESIS; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; OUTPATIENT; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; SOLID TUMOR; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030811874     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700834     Document Type: Letter

References (6)